中文

AI FOR SCIENCE · ON THE RECORD

Recursion

Industrializes cellular phenomics to create proprietary data, maps disease–target–compound relationships and monetizes through milestones and a clinical pipeline.

Direction analysis

AI4S.fyi's own reading of the public record, last checked 2026-08-04.

The claim

A proprietary-data flywheel built from industrialized phenomics can improve drug-discovery efficiency and ultimately clinical asset output.

Recursion is simultaneously a data engine, software platform and biotech bearing clinical risk; the decisive validation must come from human efficacy of platform-native assets.

Read the full analysis →

Recent timeline

People

The leadership the company's own team page lists, then the other people the AI4S.fyi record has named. Not the full team.

This page compiles what AI4S.fyi has recorded and links each item to its source. It is not a grade of the organization and not its complete history: a blank means the record has not caught up as often as it means nothing happened.